Post-acute Sequelae of COVID-19: A Metabolic Perspective

Overview

Journal Elife

Specialty Biology

Date 2022 Mar 23

PMID 35318939

Authors

Philipp E Scherer

John P Kirwan

Clifford J Rosen

Affiliations

Soon will be listed here.

Abstract

The SARS-CoV-2 pandemic continues to rage around the world. At the same time, despite strong public health measures and high vaccination rates in some countries, a post-COVID-19 syndrome has emerged which lacks a clear definition, prevalence, or etiology. However, fatigue, dyspnea, brain fog, and lack of smell and/or taste are often characteristic of patients with this syndrome. These are evident more than a month after infection, and are labeled as (PASC) or commonly referred to as long-COVID. Metabolic dysfunction (i.e., obesity, insulin resistance, and diabetes mellitus) is a predisposing risk factor for severe acute COVID-19, and there is emerging evidence that this factor plus a chronic inflammatory state may predispose to PASC. In this article, we explore the potential pathogenic metabolic mechanisms that could underly both severe acute COVID-19 and PASC, and then consider how these might be targeted for future therapeutic approaches.

Citing Articles

A Narrative Review of the Efficacy of Long COVID Interventions on Brain Fog, Processing Speed, and Other Related Cognitive Outcomes.

Whitaker-Hardin B, McGregor K, Uswatte G, Lokken K Biomedicines. 2025; 13(2).

PMID: 40002834 PMC: 11853337. DOI: 10.3390/biomedicines13020421.

Morphometric vertebral fractures at hospitalization associate with Long COVID occurrence.

Di Filippo L, Doga M, Mangini F, Gifuni L, Sahagun S, Querini P J Endocrinol Invest. 2025; .

PMID: 39932650 DOI: 10.1007/s40618-025-02544-1.

Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis.

Iqbal N, Khan H, Khalid A, Mahmood S, Nasir N, Khanum I Mol Med. 2025; 31(1):22.

PMID: 39849406 PMC: 11756069. DOI: 10.1186/s10020-024-00986-6.

Longitudinal H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection.

Mendes L, Gama-Almeida M, Reis D, Silva A, Neris R, Galliez R Viruses. 2024; 16(11).

PMID: 39599883 PMC: 11598993. DOI: 10.3390/v16111769.

Endocrine dysregulation in COVID-19: molecular mechanisms and insights.

Iosef C, Matusa A, Han V, Fraser D Front Endocrinol (Lausanne). 2024; 15:1459724.

PMID: 39502570 PMC: 11534806. DOI: 10.3389/fendo.2024.1459724.

References

Bennett T, Moffitt R, Hajagos J, Amor B, Anand A, Bissell M . Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Netw Open. 2021; 4(7):e2116901. PMC: 8278272. DOI: 10.1001/jamanetworkopen.2021.16901. View

Chen X, Chen Y, Wu C, Wei M, Xu J, Chao Y . Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes. BMJ Open Diabetes Res Care. 2020; 8(2). PMC: 7677866. DOI: 10.1136/bmjdrc-2020-001851. View

Fignani D, Licata G, Brusco N, Nigi L, Grieco G, Marselli L . SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic -Cells and in the Human Pancreas Microvasculature. Front Endocrinol (Lausanne). 2020; 11:596898. PMC: 7691425. DOI: 10.3389/fendo.2020.596898. View

Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens D . Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011; 60(7):1917-25. PMC: 3121429. DOI: 10.2337/db10-1707. View

Liu R, Pugh G, Tevonian E, Thompson K, Lauffenburger D, Kern P . Regulatory T Cells Control Effector T Cell Inflammation in Human Prediabetes. Diabetes. 2021; 71(2):264-274. PMC: 8914282. DOI: 10.2337/db21-0659. View

Song J, Zhang C, Fan X, Meng F, Xu Z, Xia P . Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020; 11(1):3410. PMC: 7343781. DOI: 10.1038/s41467-020-17240-2. View

Reiterer M, Rajan M, Gomez-Banoy N, Lau J, Gomez-Escobar L, Ma L . Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021; 33(11):2174-2188.e5. PMC: 8443335. DOI: 10.1016/j.cmet.2021.09.009. View

Vimercati L, De Maria L, Quarato M, Caputi A, Gesualdo L, Migliore G . Association between Long COVID and Overweight/Obesity. J Clin Med. 2021; 10(18). PMC: 8469321. DOI: 10.3390/jcm10184143. View

Roy K, Agarwal S, Banerjee R, Paul M, Purbey P . COVID-19 and gut immunomodulation. World J Gastroenterol. 2022; 27(46):7925-7942. PMC: 8678818. DOI: 10.3748/wjg.v27.i46.7925. View

10.

Fernandez-de-Las-Penas C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Hernandez-Barrera V . Diabetes and the Risk of Long-term Post-COVID Symptoms. Diabetes. 2021; 70(12):2917-2921. DOI: 10.2337/db21-0329. View

11.

Colca J, Scherer P . The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. Mol Metab. 2021; 55:101409. PMC: 8688722. DOI: 10.1016/j.molmet.2021.101409. View

12.

Sun B, Huang S, Zhou J . Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections. Front Pharmacol. 2021; 11:592439. PMC: 7878391. DOI: 10.3389/fphar.2020.592439. View

13.

Li Y, Schneider A, Mehta A, Sade-Feldman M, Kays K, Gentili M . SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest. 2021; 131(13). PMC: 8245177. DOI: 10.1172/JCI148635. View

14.

Zhu L, She Z, Cheng X, Qin J, Zhang X, Cai J . Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31(6):1068-1077.e3. PMC: 7252168. DOI: 10.1016/j.cmet.2020.04.021. View

15.

Asterholm I, Tao C, Morley T, Wang Q, Delgado-Lopez F, Wang Z . Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014; 20(1):103-18. PMC: 4079756. DOI: 10.1016/j.cmet.2014.05.005. View

16.

Ahmad T, Haroon , Baig M, Hui J . Coronavirus Disease 2019 (COVID-19) Pandemic and Economic Impact. Pak J Med Sci. 2020; 36(COVID19-S4):S73-S78. PMC: 7306969. DOI: 10.12669/pjms.36.COVID19-S4.2638. View

17.

Montefusco L, Ben Nasr M, DAddio F, Loretelli C, Rossi A, Pastore I . Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021; 3(6):774-785. PMC: 9931026. DOI: 10.1038/s42255-021-00407-6. View

18.

Solerte S, Di Sabatino A, Galli M, Fiorina P . Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol. 2020; 57(7):779-783. PMC: 7275134. DOI: 10.1007/s00592-020-01539-z. View

19.

Beste M, Pfaffle-Doyle N, Prentice E, Morris S, Lauffenburger D, Isaacson K . Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci Transl Med. 2014; 6(222):222ra16. PMC: 4118592. DOI: 10.1126/scitranslmed.3007988. View

20.

Leong A, Cole J, Brenner L, Meigs J, Florez J, Mercader J . Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med. 2021; 18(3):e1003553. PMC: 7971850. DOI: 10.1371/journal.pmed.1003553. View